Travoprost

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 810 publications

A Multimodal Approach to Open-Angle Glaucoma with Travoprost Intracameral Implant and Minimally Invasive Glaucoma Surgery with or Without Concurrent Cataract Surgery.

A Multimodal Approach to Open-Angle Glaucoma with Travoprost Intracameral Implant and Minimally Invasive Glaucoma Surgery with or Without Concurrent Cataract Surgery.

Journal: Ophthalmology and therapy
Published: March 30, 2026

Early Real-World Safety and Short-Term Outcomes of Combined iStent Infinite and Intracameral Travoprost Implant (iDose TR) with or without Cataract Surgery.

Early Real-World Safety and Short-Term Outcomes of Combined iStent Infinite and Intracameral Travoprost Implant (iDose TR) with or without Cataract Surgery.

Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: February 17, 2026

Twelve-Month Outcomes of Standalone Travoprost Intracameral Implant in Glaucoma or Ocular Hypertension.

Twelve-Month Outcomes of Standalone Travoprost Intracameral Implant in Glaucoma or Ocular Hypertension.

Journal: Life (Basel, Switzerland)
Published: February 17, 2026

A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension.

A Comprehensive Review of the Clinical Evidence Comparing Benzalkonium Chloride-Preserved and Benzalkonium Chloride-Free Latanoprost in the Treatment of Primary Open-Angle Glaucoma and Ocular Hypertension.

Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: January 12, 2026

Safety and Feasibility of the Exchange Procedure for the Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension.

Safety and Feasibility of the Exchange Procedure for the Travoprost Intracameral Implant for Open-Angle Glaucoma or Ocular Hypertension.

Journal: Ophthalmology and therapy
Published: December 31, 2025

Impact of Preservative-Free Travoprost on Intraocular Pressure and Ocular Surface in Primary Open-Angle Glaucoma Patients.

Impact of Preservative-Free Travoprost on Intraocular Pressure and Ocular Surface in Primary Open-Angle Glaucoma Patients.

Journal: Life (Basel, Switzerland)
Published: October 26, 2025

Progressive Visual Field Loss in the Setting of Severe Orbital Fat Atrophy.

Progressive Visual Field Loss in the Setting of Severe Orbital Fat Atrophy.

Journal: Cureus
Published: September 06, 2025

Evaluating the potential of travoprost-thymoquinone co-loaded liposomes: a glaucomatous rabbit model study.

Evaluating the potential of travoprost-thymoquinone co-loaded liposomes: a glaucomatous rabbit model study.

Journal: Therapeutic delivery
Published: August 26, 2025

Effect of Topical Travoprost 0.004% Drops on Central Corneal Thickness in Patients With Primary Open-Angle Glaucoma.

Effect of Topical Travoprost 0.004% Drops on Central Corneal Thickness in Patients With Primary Open-Angle Glaucoma.

Journal: Cureus
Published: August 23, 2025

The Effect of Preoperative Use of High- vs. Low-PAP-Inducing-Potential FP Agonists on the Surgical Outcomes of Trabeculectomy and AGV Implantation.

The Effect of Preoperative Use of High- vs. Low-PAP-Inducing-Potential FP Agonists on the Surgical Outcomes of Trabeculectomy and AGV Implantation.

Journal: Journal of clinical medicine
Published: August 22, 2025

Implants to Treat Glaucoma: Promising or Not?

Implants to Treat Glaucoma: Promising or Not?

Journal: Drugs & aging
Published: August 09, 2025

Efficacy and safety of netarsudil compared with prostaglandin-based therapies: a Bayesian network meta-analysis.

Efficacy and safety of netarsudil compared with prostaglandin-based therapies: a Bayesian network meta-analysis.

Journal: International ophthalmology
Published: August 07, 2025
Showing 1-12 of 810

Last Updated: 06/30/2026